As a Medical Informatics Specialist, Derek Pinnell, PharmD, supports Health Language solutions, focusing on medication data, providing clinical input for content and solution development, and finding innovative strategies to help clients make better use of their clinical data.
In his free time, Derek enjoys riding dirt bikes, paddle boarding, reading, and spending quality time with his wife and kids. One of the biggest rewards of his profession is helping healthcare professionals provide better patient care through improved data and technology.
He holds a Doctor of Pharmacy degree from Roseman University of Health Sciences and has further honed his expertise with certifications including the ASHP Pharmacogenomic Professional Certificate and the AMIA 10x10 Health Care Informatics Certification from Oregon Health and Science University.
As an author, his publications include:
- Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease. Medicine 101(50):p e32367, December 16, 2022. | DOI: 10.1097/MD.0000000000032367
- Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure. Medicine 102(9):p e33134, March 03, 2023. | DOI: 10.1097/MD.0000000000033134
- Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans. The American Journal of Gastroenterology 115():p S6, December 2020. | DOI: 10.14309/01.ajg.0000722884.49445.dd
- Infliximab Biosimilar Use for Inflammatory Bowel Disease: A National Veterans Affairs Experience. The American Journal of Gastroenterology 115():p S389, October 2020. | DOI: 10.14309/01.ajg.0000705108.91851.d0
- Justification for initiating patiromer when restricted by prior authorization and clinical guidance in a US health care system. Journal of Managed Care & Specialty Pharmacy, 28(12), 1410-1418.
- Veterans on anticancer medications in rural and community environment support (VA CARES) program: A pharmacist-led telemedicine medication management program for veterans receiving oral antineoplastic therapies through the MISSION Act.. JCO 39, 1545-1545(2021).
- Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and alcohol dependence, 248, 109902.
LinkedIn